Relaying what matters next.

The Relay is a new media project dedicated to covering slightly futuristic domains such as artificial intelligence, space exploration, longevity science, crypto and blockchain, advanced biology, and defense technologies. Our mission is to capture the signals of tomorrow and relay them forward with clarity, depth, and context.

What's happening today?

Citi’s September Pilot Marks the Agentic Enterprise Shift

Citi’s September Pilot Marks the Agentic Enterprise Shift

Citi’s September pilot of autonomous agents inside Stylus Workspaces marks a real move from demos to production. See how browser agents and modern orchestration reshape enterprise rollouts, why the agent cost curve matters, and a concrete blueprint with KPIs to ship in Q4 2025.

Iron Beam Goes Operational: Lasers Rewrite Air Defense

Iron Beam Goes Operational: Lasers Rewrite Air Defense

Israel says its Iron Beam laser will enter service in 2025 after completing final tests in September. A combat ready high energy laser could flip the economics of defending against rockets, mortars, and drones while reshaping tactics and procurement worldwide.

The GENIUS Act will rewire stablecoins, DeFi, and payments

The GENIUS Act will rewire stablecoins, DeFi, and payments

A builder and investor playbook for the next 6 to 18 months under the new U.S. stablecoin law. Deadlines, winners and losers, DeFi yield shifts, exchange liquidity changes, and a clear U.S. vs MiCA roadmap.

States Move to Rewire PJM as AI Load Swamps the Grid

States Move to Rewire PJM as AI Load Swamps the Grid

Governors across the PJM region are forming a new collaborative to shape grid planning and market rules as AI data center demand drives up capacity prices and reliability risk. Here is what they want to change, how it could hit bills, and the milestones to watch next.

Driest Lunar Mantle Yet Is Forcing a New Moon Playbook

Driest Lunar Mantle Yet Is Forcing a New Moon Playbook

New analyses of Chang'e-6 farside samples suggest mantle water as low as 1 to 1.5 micrograms per gram and basalt ages near 2.83 billion years. The results tighten resource expectations away from mid‑latitudes and sharpen Artemis priorities around polar ice and operations.

FDA Rollback Puts Biological Age Tests Back in Play

FDA Rollback Puts Biological Age Tests Back in Play

On September 19, 2025 the FDA implemented a court-ordered vacatur of its 2024 LDT framework, shifting oversight back to CLIA. Expect faster epigenetic clocks, proteomic age panels, and multi-omic biomarkers in clinics, along with greater variation in quality. Here is what changed and how to judge credibility.

2025’s enterprise agent stack is here: architecture and rollout

2025’s enterprise agent stack is here: architecture and rollout

Microsoft, NVIDIA, and OpenAI turned AI agents from demos into deployable systems in 2025. See why they are production ready, a secure reference architecture, real cost and latency tradeoffs, and a pragmatic 30-60-90 day rollout plan.

TLK-1000: Ukraine's long-range UUV rewrites sea power

TLK-1000: Ukraine's long-range UUV rewrites sea power

Unveiled in Lviv on Sept. 19, 2025, the TLK-1000 promises 2,000 km reach and a multi-ton payload. If it scales, autonomous deep-strike UUVs could upend naval strategy and trigger a global race to defend ports, bridges, cables, and fleets.

SEC fast-tracks crypto ETFs as DOGE and XRP funds debut

SEC fast-tracks crypto ETFs as DOGE and XRP funds debut

A quiet SEC rule change replaces one-off approvals with generic listing standards, shrinking crypto ETF timelines from months to weeks. With DOGE and XRP ETFs trading, we break down what this means for liquidity, custody, surveillance, and the road to broader crypto exposure.

AI’s power boom collides with America’s LNG export wave

AI’s power boom collides with America’s LNG export wave

Exploding AI data center demand is arriving just as a major wave of US and Qatari LNG supply hits global markets. The cross‑currents are rewriting policy from PJM to ERCOT, reshaping capacity prices, and guiding where new gas plants get built.

Autophagy, Alzheimer’s, and the Fast Track to Longevity

Autophagy, Alzheimer’s, and the Fast Track to Longevity

Retro Biosciences plans a first-in-human study of RTR242, an autophagy-enhancing pill for Alzheimer’s. Learn why a disease label can accelerate longevity drugs, the biomarker stack to watch through 2026, and how this brain-first strategy compares with partial epigenetic reprogramming.

TRAPPIST‑1e’s Atmosphere: JWST Hints Keep Nitrogen in Play

TRAPPIST‑1e’s Atmosphere: JWST Hints Keep Nitrogen in Play

Fresh JWST results from September 2025 rule out hydrogen-dominated skies for TRAPPIST-1e and make a Venus or Mars style carbon dioxide blanket unlikely. A nitrogen-rich atmosphere or a bare rock remain in play, and the next JWST transits could decide it.

Browser Becomes an Agent: Gemini in Chrome and A2A

Browser Becomes an Agent: Gemini in Chrome and A2A

Chrome is evolving from a place where you work to a partner that works for you. With Gemini moving into the browser and a new Agent2Agent protocol for interop, tasks shift from single chatbots to coordinated agents that plan, negotiate, and execute across the web.

2025: The Year Laser Air Defense Finally Went Live

2025: The Year Laser Air Defense Finally Went Live

Israel is bringing Iron Beam into service while China publicly rolled out LY‑1 and OW5 lasers. Together they signal a real shift in counter‑drone and rocket defense, where cost per shot, physics limits, countermeasures, and U.S. fielding plans collide.

Generic Listing Unlocks Solana, XRP and Memecoin ETFs

Generic Listing Unlocks Solana, XRP and Memecoin ETFs

On September 17, 2025 the SEC approved generic listing standards that let U.S. exchanges list crypto commodity-based ETPs without case-by-case 19b-4 reviews. Here is what changes for Solana, XRP and even memecoins across eligibility, liquidity, spreads and options.

CHIP becomes actionable: TET2, canakinumab and colchicine

CHIP becomes actionable: TET2, canakinumab and colchicine

Two 2025 signals shift clonal hematopoiesis from curiosity to clinical tool. A July genotype-guided trial tests canakinumab in TET2 CH, and ESC 2025 data suggest low-dose colchicine can slow TET2 clonal growth. Screening now has direct consequences.

AP2: Google’s trust-and-consent layer for AI checkout

AP2: Google’s trust-and-consent layer for AI checkout

Google’s Agent Payments Protocol standardizes how AI agents prove user intent and consent at checkout. We break down how AP2 works, what it could unlock for retailers, wallets, and issuers, and where the hard gaps remain.

NTS-3 Is Up: Reprogrammable PNT and the Next GPS Fight

NTS-3 Is Up: Reprogrammable PNT and the Next GPS Fight

Fresh off the USSF-106 launch, NTS-3 brings software-defined, beam-steered navigation from lab to orbit. Here is how agile waveforms and regional protection could reshape contested PNT, user gear, and acquisition cycles.